Smoking-Related Pathology

Smoking-related pathology is the study of disease caused by exposure to tobacco smoke. Cigarette smoke is a complex mixture of carcinogens, oxidants, and irritants that damages the airways and lung, accelerates atherosclerosis, and injures many other organs. It is the leading preventable cause of cancer, chronic obstructive pulmonary disease, and a large share of cardiovascular disease.

Definition

Smoking-related pathology refers to the spectrum of tissue injury and disease caused by tobacco smoke exposure, including carcinogenesis, chronic obstructive lung disease, and cardiovascular injury, driven by the carcinogens, oxidants, and toxicants in the smoke.

Scope

The topic covers the composition of tobacco smoke and its principal disease pathways: carcinogenesis (especially lung cancer), chronic airway and parenchymal lung injury, and cardiovascular damage through endothelial dysfunction, inflammation, and thrombosis. It is a reference account of mechanism and pathology and does not provide guidance on smoking-cessation treatment.

Core questions

• How do carcinogens in tobacco smoke initiate and promote cancer, especially in the lung?
• How does chronic smoke exposure produce airflow obstruction and emphysema?
• By what mechanisms does smoking accelerate atherosclerosis and thrombosis?
• Why does tobacco smoke injure organs far beyond the respiratory tract?

Key concepts

• Tobacco smoke carcinogens (including polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines)
• Metabolic activation and DNA adduct formation
• Field carcinogenesis
• Oxidative stress and chronic inflammation
• Protease-antiprotease imbalance and emphysema
• Endothelial dysfunction and thrombosis
• Multi-organ smoking-attributable disease

Mechanisms

Tobacco smoke contains numerous carcinogens, notably polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines, which are metabolically activated to reactive species that bind DNA and form adducts; if these are misrepaired, they cause the mutations that initiate cancer, a sequence best characterized for lung carcinogenesis (Hecht, 2012). In the airways and lung, chronic exposure to oxidants and irritants drives persistent inflammation, oxidative injury, and a protease-antiprotease imbalance that destroys alveolar walls, producing the airflow obstruction and emphysema of chronic obstructive pulmonary disease. In the vasculature, smoking promotes endothelial dysfunction, inflammation, lipid modification, a prothrombotic state, and platelet activation, which together accelerate atherosclerosis and predispose to thrombotic events (Ambrose & Barua, 2004). Because smoke constituents are absorbed systemically, these oxidative, inflammatory, and carcinogenic processes injure many organs beyond the lung (U.S. Department of Health and Human Services, 2010; Kumar, Abbas, & Aster, 2021).

Clinical relevance

Smoking-related pathology explains why tobacco use causes cancer, obstructive lung disease, and cardiovascular disease, and why these are largely preventable. It is a reference framework for the mechanisms and morphology of tobacco-attributable injury; it does not provide individualized cessation or treatment advice, which require qualified clinical care.

Epidemiology

Tobacco smoking is the leading preventable cause of death worldwide and the dominant cause of lung cancer, a major cause of chronic obstructive pulmonary disease, and a substantial contributor to cardiovascular disease, with risk rising with intensity and duration of exposure (Hecht, 2012; U.S. Department of Health and Human Services, 2010).

History

The link between smoking and disease was established in the mid-twentieth century through landmark epidemiologic studies of smoking and lung cancer, and successive Surgeon General reports consolidated the evidence. Subsequent decades clarified the biological mechanisms — carcinogen metabolism and DNA adduct formation, oxidative airway injury, and vascular damage — that connect tobacco smoke to its characteristic diseases (Hecht, 2012; U.S. Department of Health and Human Services, 2010).

Seminal works

• hecht-2012
• ambrose-barua-2004
• ushsg-2010

Frequently asked questions

How does smoking cause lung cancer?

Carcinogens in tobacco smoke are metabolically activated to reactive forms that bind DNA and form adducts; when these are misrepaired they produce mutations that, accumulating over time, initiate and drive the development of cancer.

Why does smoking damage the heart and blood vessels and not just the lungs?

Smoke constituents are absorbed into the bloodstream and promote endothelial dysfunction, inflammation, and a prothrombotic state, which accelerate atherosclerosis and raise the risk of thrombotic cardiovascular events throughout the body.